Read More

Wall Street Set For Cautious Start After Record Run Last Week — Fed Speeches, Manufacturing Data In Focus: Expert Flags This As Key Catalyst For Stocks

U.S. stocks are gearing up for a cautious start following last week’s record run, with the index futures currently showing mixed sentiment. Tech stocks could extend the strength but it remains to be seen if that pervades into the broader market.

ADSK

Read More

FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer

AstraZeneca's breakthrough drug, Imfinzi, combined with chemotherapy, has been officially approved by the FDA to treat advanced forms of endometrial cancer with mismatch repair deficiency. This critical approval is based on Phase III trial results showing a 58% reduction in disease progression, promising improved outcomes for those battling this severe cancer.

AZN